Ondine Biomedical (LON:OBI) Trading Down 11.8% – What’s Next?

Ondine Biomedical Inc. (LON:OBI) was down 11.8% on Monday . The company traded as low as C$12.00 and last traded at C$12.10. 1,571,263 shares were traded during mid-day trading, an increase of 265% from the average daily volume of 430,291 shares. The stock had previously closed at C$13.71.

Ondine Biomedical Trading Up 7.4%

The company has a debt-to-equity ratio of 11.85, a current ratio of 1.23 and a quick ratio of 8.26. The company has a market capitalization of C$6.75 billion, a P/E ratio of -2.17 and a beta of 0.31. The firm has a fifty day moving average price of C$14.00 and a 200-day moving average price of C$12.44.

About Ondine Biomedical

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens.

Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target.

Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.